Policy to advance pharmaceutical research and development. 340B.
2025 · 2nd Quarter (Apr 1 - June 30)
EXELIXIS, INC.
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 19, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Client
- EXELIXIS, INC.
- Filing UUID
- 374672f0-4a9b-40ed-bde4-bebf838ba0bd
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Implementation of Inflation Reduction Act of 2022.
Intellectual property.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.